---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003053"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:12:10.965920+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PAVmed exchanges $22.35M of convertible notes for Series C preferred; targets Nasdaq compliance

## Summary
- Exchanged $22,347,543 in principal plus interest of Senior Secured Convertible Notes for 22,347 Series C Preferred shares.
- Remaining outstanding principal on Convertible Notes is approximately $6.6 million.
- Potential dilution: at voluntary conversion price $1.068/share, ~20.9M common shares; at floor $0.2136, ~104.6M shares.
- Company executed exchange to bolster stockholders' equity to meet Nasdaq minimum of $2.5M; compliance deadline Jan 31, 2025.

## SEC filing metadata
- accession: 0001493152-25-003053
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 3.02, 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/0001493152-25-003053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003053
- JSON: https://secwatch.observer/filing/0001493152-25-003053.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.